Vyne Therapeutics Inc (NASDAQ:VYNE)
| 3.50 Delayed Data As of Dec 06 |  +0.06 / +1.72%Today’s Change | 1.99 Today|||52-Week Range 8.73 | +29.63% Year-to-Date |
Institutional investors purchased a net $1.2 million shares of VYNE during the quarter ended June 2019, and now own 37.62% of the total float, a percentage that is typical for companies in the Pharmaceuticals: Major industry.
| Other institutional | 36.84% |
| Individual stakeholders | 0.88% |
| Mutual fund holders | 0.78% |
Largest Quarterly Institutional
Transactions
Latest Institutional Activity
| 11/03/2023 | CITADEL ADVISORS LLC Bought 1.2 Million shares of Vyne Therapeutics Inc |
| 9/30/2023 | U.S. BANK NA (CINCINNATI OHIO IN... Bought 4.4 Thousand shares of Vyne Therapeutics Inc |
| 9/30/2023 | GEODE CAPITAL MANAGEMENT LLC Bought 2.6 Thousand shares of Vyne Therapeutics Inc |
Top 10 Owners of Vyne Therapeutics Inc
| Stockholder | Stake | Shares owned | Total value ($) | Shares bought / sold | Total change |
|---|---|---|---|---|---|
| Cormorant Asset Management LP | 9.99% | 1,394,336 | 4,252,725 | 0 | 0.00% |
| Eventide Asset Management LLC | 9.99% | 1,394,336 | 4,252,725 | 0 | 0.00% |
| Citadel Advisors LLC | 8.46% | 1,181,088 | 3,602,318 | +1,181,088 | -- |
| Soleus Capital Management LP (Inv... | 6.38% | 890,868 | 2,717,147 | 0 | 0.00% |
| DSC Advisors LP | 0.82% | 115,000 | 350,750 | 0 | 0.00% |
| Susquehanna Financial Group LLLP | 0.44% | 60,697 | 185,126 | +187 | +0.31% |
| BlackRock Fund Advisors | 0.32% | 44,939 | 137,064 | -4,103 | -8.37% |
| The Vanguard Group, Inc. | 0.31% | 43,891 | 133,868 | -1 | -0.00% |
| Geode Capital Management LLC | 0.20% | 27,534 | 83,979 | +2,589 | +10.38% |
| Renaissance Technologies LLC | 0.19% | 25,976 | 79,227 | -10,100 | -28.00% |
Top 10 Mutual Funds Holding Vyne Therapeutics Inc
| Mutual fund | Stake | Shares owned | Total value ($) | Shares bought / sold | Total change |
|---|---|---|---|---|---|
| Vanguard Extended Market Index Fu... | 0.31% | 43,891 | 133,868 | 0 | 0.00% |
| Fidelity Extended Market Index Fu... | 0.12% | 17,267 | 52,664 | +2,567 | +17.46% |
| Vifag 2002, SICAV | 0.07% | 10,382 | 31,665 | +29 | +0.28% |
| Mackenzie US Quantitative Small C... | 0.07% | 9,667 | 29,484 | +2,171 | +28.96% |
| abrdn Healthcare Investors | 0.04% | 5,265 | 16,058 | 0 | 0.00% |
| Franklin U.S. Small Cap Equity Fu... | 0.04% | 5,196 | 15,848 | 0 | 0.00% |
| Fidelity Total Market Index Fund | 0.03% | 4,217 | 12,862 | 0 | 0.00% |
| DFA US Small Cap Portfolio | 0.03% | 3,873 | 11,813 | 0 | 0.00% |
| Fidelity Series Total Market Inde... | 0.02% | 2,650 | 8,083 | 0 | 0.00% |
| abrdn Life Sciences Investors | 0.02% | 2,255 | 6,878 | 0 | 0.00% |